Quarterly report [Sections 13 or 15(d)]

Condensed Statement of Changes in Stockholders??? Equity (Unaudited)

v3.25.1
Condensed Statement of Changes in Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   26,329,032    
Beginning balance at Dec. 31, 2023 $ 15,937 $ 3 $ 52,759 $ (36,825)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense 1,207   1,207  
Net loss (4,606)     (4,606)
Ending balance (in shares) at Mar. 31, 2024   26,329,032    
Ending balance at Mar. 31, 2024 $ 12,538 $ 3 53,966 (41,431)
Beginning balance (in shares) at Dec. 31, 2024 26,960,901 26,960,901    
Beginning balance at Dec. 31, 2024 $ 1,654 $ 3 57,924 (56,273)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense 1,109   1,109  
Sale of Common Stock, net of issuance costs (in shares)   6,746,386    
Sale of Common Stock, net of issuance costs $ 10,250   10,250  
Stock issuance upon exercise of stock options (in shares) 58,805 27,261    
Net loss $ (5,484)     (5,484)
Ending balance (in shares) at Mar. 31, 2025 33,734,548 33,734,548    
Ending balance at Mar. 31, 2025 $ 7,529 $ 3 $ 69,283 $ (61,757)